Patents by Inventor David Bachinsky

David Bachinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEK ligands and polynucleotides encoding MEK ligands
    Patent number: 9006390
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate MEK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands, homopolyligands, and heteropolyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: April 14, 2015
    Assignee: Intrexon Corporation
    Inventors: David Bachinsky, Jonathan Carson, Amy Atzel, Thomas Reed
  • MEK Ligands and Polynucleotides Encoding MEK Ligands
    Publication number: 20140073028
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate MEK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands, homopolyligands, and heteropolyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: October 4, 2013
    Publication date: March 13, 2014
    Applicant: Intrexon Corporation
    Inventors: David BACHINSKY, Jonathan Carson, Amy Atzel, Thomas Reed
  • MEK ligands and polynucleotides encoding MEK ligands
    Patent number: 8575304
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate MEK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands, homopolyligands, and heteropolyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: March 27, 2008
    Date of Patent: November 5, 2013
    Assignee: Intrexon Corporation
    Inventors: Thomas Reed, Amy Atzel, David Bachinsky, Jonathan Carson
  • PP1 ligands
    Patent number: 8455628
    Abstract: The invention relates to phosphatase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate PP1 activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands, homopolyligands, and heteropolyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Grant
    Filed: May 2, 2008
    Date of Patent: June 4, 2013
    Assignee: Intrexon Corporation
    Inventors: Thomas Reed, Amy Atzel, David Bachinsky, Anna Tretiakova
  • MEK Ligands and Polynucleotides Encoding MEK Ligands
    Publication number: 20100279378
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate MEK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands, homopolyligands, and heteropolyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: March 27, 2008
    Publication date: November 4, 2010
    Inventors: David Bachinsky, Jonathan Carson, Amy Atzel, Thomas Reed
  • PP1 Ligands
    Publication number: 20100273212
    Abstract: The invention relates to phosphatase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate PP1 activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands, homopolyligands, and heteropolyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: May 2, 2008
    Publication date: October 28, 2010
    Applicant: Intrexon Corporation
    Inventors: Thomas Reed, Amy Atzel, David Bachinsky, Anna Tretiakova